DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
André F, O’Regan R, Ozguroglu M. et al.
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet Oncol 2014;
15 (06) 580-591
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.